Show simple item record

dc.creatorĐekić, Ljiljana
dc.date.accessioned2019-09-02T11:56:42Z
dc.date.available2019-09-02T11:56:42Z
dc.date.issued2016
dc.identifier.urihttp://farfar.pharmacy.bg.ac.rs/handle/123456789/2768
dc.description.abstractThis chapter reviews the current progress in liposome based pharmaceuticals with particular emphasis on the carrier design, size, surface properties, drug delivery performances and therapeutic applications for different routes of administration. There were described selected examples of encapsulation of drug substances by liposomes which allowed improvement of therapeutic index of cytotoxic drugs (such as antineoplastics, antibiotics) or sustained drug release and reduction of the frequency of administration of analgesics and local anesthetics, and potentiate the immunogenicity of vaccines against hepatitis A and influenza. Furthermore, the performances of the marketed pharmaceuticals which represent pulmonary surfactant substituents (in the form of liposome vesicles) in premature infants and topical preparations with high molecular weight actives (e.g., heparin sodium) encapsulated in liposomes, were highlighted. The most important factors that affect the development of new drugs with this type of nanomaterials and their safety were commented.en
dc.publisherIGI Global
dc.rightsrestrictedAccess
dc.sourceNovel Approaches for Drug Delivery
dc.titleLiposomes: Properties and therapeutic applicationsen
dc.typebookPart
dc.rights.licenseARR
dcterms.abstractЂекић, Љиљана;
dc.citation.spage27
dc.citation.epage51
dc.citation.other: 27-51
dc.identifier.doi10.4018/978-1-5225-0751-2.ch002
dc.identifier.scopus2-s2.0-85014004505
dc.identifier.rcubconv_4691
dc.type.versionpublishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record